NEW YORK (GenomeWeb News) – Cancer Genetics today announced the public offering of 1.5 million shares of its common stock at $10 per share and the migration of its stock to the Nasdaq Capital Market.

Its stock had been trading on the OTC QB since the company went public in April.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.